Home Tags Cannabis

cannabis Related Content

OCD symptoms, CBD

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
CBG

CBG: The mother of all Cannabinoids with broad antibacterial activity

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
savage cabbage

Savage Cabbage: Where did it begin?

In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.
EUMCA, Brexit

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
narcotic

CBD: Narcotic substance or a novel food product?

CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
compliance for medical cannabis

Ensuring regulatory compliance for Medical Cannabis

Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
medical application of CBD, covid

COVID is shifting the conversation about the medical application of CBD

Hannah Deacon, co-founder of Maple Tree Consultancy, explores how COVID is elevating and shaping the medical application of CBD.
CBD in the UK, dose

A comprehensive guide to CBD in the UK

Here, Professor Mike Barnes discusses and answers some key questions about the world of CBD in the UK.
Quality of medicinal cannabis, purely plant

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
series B equity financing, mile high

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
import of medical cannabis, drug

The import of medical cannabis: Germany and the Netherlands

Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
CBD novel food applications

The European Commission’s ‘pause’ on CBD novel food applications

Associate, David Hardstaff and Partner, John Binns at BCL Solicitors LLP, explain here how cannabis wonder child takes a knock in light of the European Commission’s ‘pause’ on CBD novel food applications mean for this booming industry.
chronic pain diseases, cannabinoids

Chronic pain diseases and medical cannabis

Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.
THC in CBD, EUMCA

EUMCA: Limit of 0.2% THC in CBD products should not change

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
medical cannabis

How are different types of medical cannabis working for different diseases?

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
pain medicine

How cannabinoids can be used as pain medicine

Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
access to medicinal cannabis, trevor jones

The EUMCA: Pioneering access to medicinal cannabis

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
cannabinoid research

Expanding the portfolio of rigorous cannabinoid research with new funding opportunities

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.
Greenheart CBD

Greenheart CBD: A green crop from seed to shelf

Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.

Follow Open Access Government